Crystalline oxazine derivative
    3.
    发明授权
    Crystalline oxazine derivative 有权
    结晶恶嗪衍生物

    公开(公告)号:US08524897B2

    公开(公告)日:2013-09-03

    申请号:US13347067

    申请日:2012-01-10

    Applicant: Rita Ramos

    Inventor: Rita Ramos

    CPC classification number: A61K45/06 C07D413/12

    Abstract: The invention relates to 5-cyano-3-methyl-pyridine-2-carboxylic acid [3-((3R,6R)-5-amino-3,6-dimethyl-6-trifluoromethyl-3,6-dihydro-2H-[1,4]oxazin-3-yl)-4-fluoro-phenyl]-amide in crystalline form, to its preparation, its medical use and to medicaments comprising said compound in crystalline form.

    Abstract translation: 本发明涉及5-氰基-3-甲基 - 吡啶-2-甲酸[3 - ((3R,6R)-5-氨基-3,6-二甲基-6-三氟甲基-3,6-二氢-2H- [1,4]恶嗪-3-基)-4-氟 - 苯基] - 酰胺,其制备方法及其医疗用途以及包含结晶形式的所述化合物的药物。

    Novel Crystalline Oxazine Derivative
    6.
    发明申请
    Novel Crystalline Oxazine Derivative 有权
    新型结晶恶嗪衍生物

    公开(公告)号:US20120178745A1

    公开(公告)日:2012-07-12

    申请号:US13347067

    申请日:2012-01-10

    Applicant: Rita RAMOS

    Inventor: Rita RAMOS

    CPC classification number: A61K45/06 C07D413/12

    Abstract: The invention relates to 5-cyano-3-methyl-pyridine-2-carboxylic acid [3-((3R,6R)-5-amino-3,6-dimethyl-6-trifluoromethyl-3,6-dihydro-2H-[1,4]oxazin-3-yl)-4-fluoro-phenyl]-amide in crystalline form, to its preparation, its medical use and to medicaments comprising said compound in crystalline form.

    Abstract translation: 本发明涉及5-氰基-3-甲基 - 吡啶-2-甲酸[3 - ((3R,6R)-5-氨基-3,6-二甲基-6-三氟甲基-3,6-二氢-2H- [1,4]恶嗪-3-基)-4-氟 - 苯基] - 酰胺,其制备方法及其医疗用途以及包含结晶形式的所述化合物的药物。

Patent Agency Ranking